Xeloda
Roche dealt with two late-stage blows
December 19, 2014Sales and Marketing Alzheimer's, Alzheimer’s, Cancer, Kadcyla, Perjeta, Roche, Xeloda, trastuzumab emtansine
Swiss giant Roche’s breast cancer treatment Kadcyla has failed to meet its primary endpoint and its investigational Alzheimer’s treatment trial …
Eisai restates Halaven’s challenge to Roche’s Xeloda
September 30, 2013Research and Development, Sales and Marketing ECC, Halaven, Roche, Xeloda
Eisai has updated research on its breast cancer drug Halaven in a renewed bid to establish the treatment as a …
GSK and Roche get EU breast cancer indication
August 15, 2013Sales and Marketing GSK, Herceptin, Roche, Tyverb, Xeloda, breast cancer
The European Commission has granted a new indication for the use of GSK’s breast cancer drug Tyverb in combination with …
Roche to submit Herceptin successor to regulators
April 2, 2012Research and Development, Sales and Marketing GSK, Herceptin, Roche, Xeloda
Roche has said it will submit its new breast cancer drug trastuzumab for regulatory review in the US and Europe …
GSK pulls Tyverb extension in Europe
February 17, 2012Sales and Marketing GSK, Herceptin, Tyverb, Xeloda
GlaxoSmithKline has withdrawn its European application to extend the licence of its breast cancer pill Tyverb. The firm was seeking …
FDA approves Eisai breast cancer drug Halaven
November 16, 2010Sales and Marketing Cancer, Eisai, FDA, Halaven, Xeloda, breast cancer, eribulin mesylate, metastatic breast cancer
The FDA has approved Eisai’s advanced breast cancer drug Halaven for use in heavily pre-treated breast cancer patients. Halaven (eribulin …
NICE approves trio of cancer drugs
July 28, 2010Sales and Marketing Iressa, MabThera, NICE, Xeloda
NICE has given its final recommendation to a trio of drugs for the treatment of various cancers, which means the …
Eisai’s breast cancer drug impresses at ASCO
June 9, 2010Research and Development ASCO, Eisai, Xeloda, eribulin
A new cancer drug developed by Japanese pharma company Eisai has shown promise in increasing overall survival rates in heavily …
Xeloda for gastric cancer gains NICE nod
June 2, 2010Sales and Marketing UK, Xeloda
NICE has recommended Roche’s Xeloda as a first line treatment of inoperable advanced gastric cancer.The cost-effectiveness body says the oral …
Roche’s Xeloda widens licence
April 1, 2010Sales and Marketing Cancer, Roche, Xeloda, colorectal cancer
Roche’s oral chemotherapy drug Xeloda has been approved in Europe in combination with intravenous oxaliplatin for the treatment of patients …
Roche eyes expanded colon cancer label for Xeloda
July 20, 2009Research and Development, Sales and Marketing Roche, Xeloda
Roche is set to expand Xeloda's colon cancer indication, after a new combination of the drug was shown to increase …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
